The therapeutic potential of psychedelics (psilocybin, LSD, DMT, ayahuasca) is increasingly shown by clinical studies and is proposed to result from increases in neuroplasticity - the brain’s ability to change throughout life. This systematic literature review summarizes the evidence that psychedelics induce neuroplasticity by focusing on psychedelics’ cellular and molecular neuroplasticity effects after single and repeated administration, as investigated in… Continue reading Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Kim Kuypers spoke with NPO Radio 1, about LSD, microdosing, and our ongoing microdosing trial. Listen to the podcast here.
BBC World Service, 24-8-2018 "LSD, magic mushrooms, mescaline, peyote - just some of the most well known psychedelic drugs. Most of them are illegal around the world. Research into psychedelic medicine was virtually shut down in the West because psychedelics were considered mind-altering substances open to abuse. This perception is changing. There is a growing body… Continue reading A New Perspective on Psychedelics
VPRO Trees 26/06/2018 Kun je structureel beter functioneren door dagelijks gebruik te maken van microdoses lsd? Volkan zoekt het uit. Gesprekken met o.a. Kim Kuypers. Find podcast here